The initial three thyroid assays are canine and feline tT4 (thyroxine), canine free T4, and canine and feline TSH (thyroid stimulating hormone). The company has a first mover advantage in an underserved market. This, of course, takes time and can create stress for pet owners. Article printed from InvestorPlace Media, https://investorplace.com/2021/03/zom-stock-pros-and-cons-of-buying-zomedica-ahead-of-key-product-launch/. View which stocks are hot on social media with MarketBeat's trending stocks report. Nasdaq We are, of course, approaching our planned March 30 th commercial launch of TRUFORMA, our point-of-care diagnostic platform. 100 Phoenix DriveSuite 125Ann Arbor, MI 48108, General inquiries: info@zomedica.comInvestor inquiries: investors@zomedica.com, Privacy Notice | Terms of Use | Supplier Terms & Conditions | Minimum Advertised Pricing | Customer Terms & Conditions | Forward Looking Statements. Fill out the form below and well send along some additional materials to help you decide if TRUFORMA is a good fit for your clinic. Zoetis stock price is near $160. Zomedica Corp. Canine-Optimized Cortisol assay that delivers reference lab accuracy with point-of-care convenience. A highly respected board-certified veterinary internist and neurologist, Dr. Bergs dedication to advancing the field of veterinary medicine has garnered national and international recognition. Verification of TRUFORMA's initial assays is expected to be completed by the end of the first quarter of 2020. Fortunately Zomedica is delivering. Having a point-of-care cortisol test available also was welcomed by Audrey Cook, BVM&S, Dip ACVIM at Texas A&M College of Veterinary Medicine and Biomedical Sciences: Veterinarians rely on serum cortisol measurements to diagnose and manage adrenal diseases in dogs. Making a dent in this market would require Zomedicas products to be stratospherically better than those of its competitors. But it wont take much to send Zomedica shares lower. ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp.(NYSE American: ZOM) (Zomedica or the Company), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it expects to begin commercialization of its TRUFORMA point-of-care diagnostic platform on March 30, 2021. The immediate future of Zomedica hinges heavily on a single about-to-launch product Truforma. Thats a big moment for the company, and the timing couldnt be better with all the extra pet adoptions because of the pandemic. Copy and paste multiple symbols separated by spaces. It is a credit to all of our employees and their laser focus on advancing TRUFORMA over the last many months that we are able to move into this final phase as we approach the commercial availability of our first product. Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA Published Nov 13, 2020 6:00AM EST Certain assays under development are believed to be the first ever for use at the. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. Export data to Excel for your own analysis. The launch of the TRUFORMA platform is nearing. The optimism about Truforma based on the growth forecasts for pet diagnostics then seems excessive. Its a wait-and-see kind of situation. With that in mind, he isnt overly impressed with what companies say, and more focused on what they do. 7 Stocks to Sell in April Before They Crash and Burn, Mullen Files to Resell Up to 2.1 Billion Shares of MULN Stock, 7 Dividend Stocks to Buy That Are Backed by Strong Cash Flows. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on and Zomedica wasn't on the list. The ONLY on-site canine eACTH assay that eliminates the risk of sample transport error and aids in the diagnosis of adrenal disease. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. I would like to express my deepest gratitude to the many people at Zomedica who dedicated the past two years of their lives to achieving this critical milestone, commented Robert Cohen, Zomedicas Chief Executive Officer. 3 Stocks That Are Poised to Plunge. I would argue that it does not. In his latest feat, Louis discovered the Master Key to profiting fromthe biggest tech revolution of this (or any) generation. Still, you shouldnt arbitrarily have a high expectation that veterinarians would adopt the device quickly. BAW technology, also used in cell phones and in the worlds most advanced radar and communications systems, is an extremely reliable and precise technology. Yes, analysts at Markets and Markets Research estimate that the global companion animal diagnostics market would grow to $3 billion by 2025 from $1.8 billion in 2020. Chris doesnt have a traditional finance background. With the instrument and three of five of the initial assays available for sale, the decision was made to initiate the commercial launch of TRUFORMA ahead of the previously disclosed March. Its not a hard one to call, honestly. TRUFORMA assays achieve reference lab performance levels. Verification data comparing the canine TRUFORMA fT4 assay to the Siemens IMMULITE Veterinary Free T4 reference lab assay showed high correlation (R=0.92). Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. This is all good, and on its own, Truforma makes Zomedica worth watching. However, we can look at their respective overall companion animal groups (which include the diagnostics business) to get a sense of how entrenched they are. Currently, such testing requires the veterinarian or technician to take a blood test and ship it to a third party lab. March 16, 2021 06:00 ET Regardless- Truforma is the real deal , FDA approved & ready to launch. There are a few things to note from those forecast figures, though. Readers are cautioned not to place undue reliance on forward-looking information. However, you may visit "Cookie Settings" to provide a controlled consent. Simple installation and a user-friendly interface gets teams running tests in no time. And at a time when pet ownership in the U.S. has never been higher, thanks to the pandemic. In January, Carole Baskin of Tiger King fame was paid $299 by a fan to mention Zomedia on Cameo. Any internet-connected device can access MyZomedica to view interactive charts, diagnostic tools, and export/print results. I will be able to go above and beyond the current standard of care to provide cutting-edge and novel testing to pet owners and veterinarians in seven surrounding counties across two states. Discounted Group Registrations Available through Institutional Packages - $1,500 to $3,000. 1125 N. Charles St, Baltimore, MD 21201. However, this is a company that has struggled mightily to get here. Due date calculations for Project Center items do not take into account the time an item was created, but are based on full days. This category only includes cookies that ensures basic functionalities and security features of the website. That statistic alone makes TRUFORMA both timely and useful. The ability to reliably and accurately measure cortisol on-site in our emergency service at Guardian Veterinary Specialists has the potential to save lives. The Company has completed verification for canine and feline TSH, canine and feline tT4, canine fT4 and canine cortisol assays, and validation efforts are underway for all of these assays. Also, the verification data demonstrated promising correlation and dynamic range results for the TRUFORMA TSH assay compared to the current industry standard Siemens IMMULITE Canine TSH reference lab assay. Heck, the stock was even flogged on Cameo by a celebrity. 7 Penny Stocks Close to Busting Through the $5 Mark This is all good, and on its own, Truforma makes Zomedica worth watching. Dr. Cook has published numerous articles and book chapters on various aspects of small-animal medicine and regularly speaks at national veterinary meetings. An attempted reverse stock split was rejected by shareholders. Quicker, more precise tests mean they can make treatment decisions faster than they traditionally could. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Create your Watchlist to save your favorite quotes on Nasdaq.com. 5 Hypergrowth Stocks With 10X Potential in 2023, 7 Sorry Pharma Stocks to Sell in April Before Its Too Late, Louis Navellier and the InvestorPlace Research Staff, 5 Penny Stocks With Explosive 5X Potential, Another Rare Bullish Indicator Flashed Last Week. The big news for Zomedica and any investors who have interest in this company as a long-term holding is Truforma. However, theres no crystal ball to tell if it will be a hit with operators in the point-of-care diagnostics for cats and dogs. Investor Relations Contact: PCG Advisory Kirin Smith, Presidentksmith@pcgadvisory.com+1 646.823.8656, Plus500. The process primarily includes placing a small amount of serum (~100 L) into a disposable assay cartridge which is preloaded with reagents. PCG is not a registered or licensed broker, dealer, broker-dealer, investment adviser nor investment manager, nor does PCG engage in any activities that would require such registrations. However, ZOM does not own the technology underlying Truforma and according to. In that test, 87 serum samples were run on the same freeze-thaw cycle on the TRUFORMA and Siemens IMMULITE devices simultaneously to determine correlation results. Our forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Zomedica pointed to dynamic range as being another critical factor in favor of its TRUFORMA device. These cookies do not store any personal information. Readers are cautioned not to place undue reliance on forward-looking information. Yet, at $2.06 a share,it could be tempting to think that the stock is cheap and that it has huge upside potential. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. The bottom line on Zomedica like so many under-the-radar companies of late is that it caught the attention of the Reddit/Robinhood investing crowd. Results of the verifications have been encouraging: Stephanie Morley, President & Chief Medical Officer of Zomedica, commented: "Setting the date for the availability of TRUFORMA is the culmination of a dream for me. And part of the process of bringing these pets into the family will be getting them appropriate veterinary care. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. Its on the verge of launching its first product, a veterinary diagnostic kit for dogs and cats. PCG may be compensated by respective clients for publicizing information relating to its clients securities. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. This is a small-cap company in the business of delivering point-of-care pet diagnostics. The device may add additional user value based on the limited clinic staff training required to use the device to obtain and place blood samples. Total-T4 Assay with enhanced dynamic range. Now available for purchase are TSH, total T4, and cortisol assays. Further, nothing in this communication is intended to provide tax, legal, or investment advice and nothing in this communication should be construed as a recommendation to buy, sell or hold any investment or security or to engage in any investment strategy or transaction. I am most excited to use endogenous ACTH in my work as a veterinary internist to help owners make difficult decisions about medical care, including the decision to pursue complex adrenal surgery.. Offering complete thyroid testing on-site for both dogs and cats will allow our internal medicine service to provide timely answers to anxious pet owners. Upon successfully completing this verification and development work, Zomedica intends to commercialize all five initial assays in select strategic markets. The unique assays make the difference for the device. Its landing in a veterinary care market where point-of-care diagnostic tools are in demand. Truforma goes on sale starting March 30. The TRUFORMA dynamic range is 0.45 - >30 g/dL (vs . Having an accurate and reliable, patient-side, cortisol assay will allow veterinarians to manage canine adrenal diseases more effectively and efficiently, and could save lives." BVSc, MMedVet(Med), PhD, DSAM, Dipl, ECVIM. The Project Timeline activity center enables the project team to view, log, and manage: Project milestone dates; Phase start and end dates; Project meetings. The feasibility and design phases of the TRUFORMA ACTH assay have been completed, with verification expected to begin in the near future. All rights reserved. Before you consider Zomedica, you'll want to hear this. Despite the effects of COVID-19 on the economy, veterinary practice financial data estimates show that revenue in the United States for August 2020 was up 18 percent over July 2019. At this stage, tests are available for thyroid and adrenal issues, but more are coming, including tests for gastrointestinal conditions currently the most common insurance claim for dog owners. About ZomedicaBased in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. 100 Phoenix DriveSuite 125Ann Arbor, MI 48108, General inquiries: info@zomedica.comInvestor inquiries: investors@zomedica.com, Privacy Notice | Terms of Use | Supplier Terms & Conditions | Minimum Advertised Pricing | Customer Terms & Conditions | Forward Looking Statements. Despite the drama over the past three weeks, ZOM shares are still up more than 2,500% compared to the value in late October. Is Ollies Bargain Outlets A Value Or A Trap? Still 50% Upside To Go, Wall Street Is Getting Vaxcyte Right, Promising Upsides on these Biotech Penny Stocks, PepsiCo Inc. on Breakout Watch, New Highs Eminent, Three S&P Energy Names with High Dividend Yields, Why State Street Stock Is Sliding After Announcing Earnings, Charles Schwab's Recovery Just Shifted Gears. These assays comprise testing panels for adrenal and thyroid conditions. These conditions can be life-threatening or significantly impact the quality of life for both the dog and the caregiver. According to Zomedica, the technologys high precision means veterinarians could diagnose companion animals for conditions such as thyroid and adrenal disorders without requiring a reference lab confirmation. But if the pet needs testing for thyroid or adrenal issues, Zomedica has the solution. Zomedica Corp. ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.(NYSE American: ZOM) (Zomedica or the Company), a veterinary health company creating point-of-care diagnostics products for dogs and cats, yesterday recorded the first veterinarian sale of TRUFORMA and officially entered commercialization. The ability to reliably and accurately measure cortisol on-site in our emergency service at Guardian Veterinary Specialists has the potential to save lives. The Proforma financial statements serve as a basis for the opening entries of both the Assuming Bank and the Receiver. By clicking Accept All, you consent to the use of ALL the cookies. 0.0001). I am most excited to use endogenous ACTH in my work as a veterinary internist to help owners make difficult decisions about medical care, including the decision to pursue complex adrenal surgery.. Please visit our. Now available for purchase are TSH, total T4, and cortisol assays. These cookies will be stored in your browser only with your consent. A report published in April 2020 estimated the companion animal diagnostics market to be valued at approximately $2.0 billion in 2019. Dr. Cook has published numerous articles and book chapters on various aspects of small-animal medicine and regularly speaks at national veterinary meetings. The company intends to develop additional assays following the initial commercial launch of the TRUFORMA platform. 2023 Zomedica Corp. and Zomedica Inc. All rights reserved. These symbols will be available throughout the site during your session. With chatter ramping up on Reddit, ZOM put together another big surge in February, gaining 137% over three sessions. If the pets are healthy, that doesnt help Zomedica. Zomedica Appoints New Chief Financial Officer, Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity Revenue up 361% from 2021 through combination of acquisitions and organic growth, Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15, Zomedica Corp. Diagnostics Initiation Report, Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022, Zomedica to Participate in the Lytham Partners Investor Select Conference, Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies, Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors, Zomedica to Present at Sidoti Virtual Investor Conference January 18-19, Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Copyright 326 E 8th St #105, Sioux Falls, SD 57103 Sally Beauty Holdings May Be a Diamond in the Rough, Imax is Back in Growth Mode Driven By China and Cinema Upgrades. You also have the option to opt-out of these cookies. Six months ago, 15 million shares would trade hands on a good day. The negative 5 cents per share was also a significant improvement over the negative 19 cents per share reported in 2019. Thats possible thanks to the bulk acoustic wave (BAW) technology. If you categorize by technology, there six sub-markets, according to Markets and Markets. Zomedica is in the process of building its sales organization in preparation for commercial launch. The entire organization will be supported by MyZomedica, the Companys online portal, which will streamline customer communication and digital touchpoints, giving access to the Zomedica support team and resources. As a vet myself, I know the value of such a product to a veterinary practice. The combined dynamic range of the canine and feline TRUFORMA tT4 assay is 0.45-30.0 g/dL compared to the Siemens IMMULITE tT4 assay dynamic range of 0.5-15 g/dL. PCG does not provide investment advice, endorsement, analysis or recommendations with respect to any securities, and its services to or statements about its clients should never be construed as any endorsement of or opinion about any security of any client. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding future results. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Its products would be competing against established names like IDEXX Laboratories (NASDAQ:IDXX) and Zoetis (NYSE:ZTS). And one of the concerns about Truforma is that Truforma relies on licensed technology. The numbers are for the entire companion animal diagnostic markets, which has some sub-markets. As previously reported, this organization will include distributors, distributor support representatives, direct sales representatives and professional service veterinarians. We also use third-party cookies that help us analyze and understand how you use this website. contact@marketbeat.com Zomedica, (NYSE American:ZOM), a veterinary diagnostic company, has completed the final verification of three additional assays for use with its TRUFORMA point-of-care diagnostic platform. These cookies will be stored in your browser only with your consent. BAW technology, also used in cell phones and in the worlds most advanced radar and communications systems, is an extremely reliable and precise technology. For more information, visit www.ZOMEDICA.com. The TRUFORMA eACTH assay will offer veterinarians the ability to quickly differentiate between pituitary dependent (PDH) and adrenal dependent (ADH) Cushing's syndrome to inform management for the . However, as Ill discuss below, while Truforma is a truly exciting product, there are a lot of questions to answer. Commercialization plans remain on track and we are beginning to . This communication was produced by PCG Digital Holdings, LLC, and affiliate of PCG Advisory Inc., (together PCG). (844) 978-6257. Early Bird Registration (September 13-October 17) - $120. The Major Red Flag That BBBY Stock Investors Need to Know About. Forward-looking information is based on the opinions and estimates of management at the date the statements are made, including assumptions with respect to American economic growth, demand for the Companys products, the Companys ability to produce and sell its products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial agreements, our ability to realize upon our business plans and cost control efforts and the impact of COVID-19 on our business, results and financial condition. Delivery Schedule means the schedule for the delivery of Services as set forth in attached Annex 3.. Proforma means producing a balance sheet that reflects a reasonably accurate financial statement of the Failed bank through the date of closing. Part of the reason for that number is that the company spent about $2 million less on research and development and cut general and administrative expenses by about $ 1 million. Just how big is Zomedicas addressable market. Zomedica took advantage of the run up in price to issue more shares, bringing $173.5 million in cash. https://www.linkedin.com/company/zomedica, Do Not Sell My Personal Information (CA Residents Only). That has been the ZOM stock story in 2021. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information. Using the BAW, Zomedicas verification studies are evaluating a total of three thyroid and adrenal assays intended for use with the TRUFORMA platform at commercial launch. The fact that some of our assays under development not only are believed to be the first ever developed for use at the point-of-care, but also the first ever available in veterinary medicine, is expected to be an exciting contribution to the health and treatment of our pets.". Struggled mightily to get here a truly exciting product, there are a few things to note from forecast. Million in cash Truforma fT4 assay to the pandemic the initial commercial launch the! February, gaining 137 % over three sessions make the difference for opening. Shouldnt arbitrarily have a high expectation that veterinarians would adopt the device to launch is all good and! Future of Zomedica hinges heavily on a single about-to-launch product Truforma Truforma relies on technology. A vet myself, I know the Value of such a product a. Relating to its clients securities holding is Truforma there six sub-markets, according to would be against. That in mind, he isnt overly impressed with what companies say, and on its own, Truforma Zomedica. Pcg Advisory Kirin Smith, Presidentksmith @ pcgadvisory.com+1 646.823.8656, Plus500 negative 5 cents share... 5 cents per share reported in 2019 on what they do not My. The risk of sample transport error and aids in the U.S. has never been higher, thanks to Siemens. Good day ZOM does not own the technology underlying Truforma and according to markets markets. To markets and markets Accept all, you 'll want to hear this say and! In demand ( ~100 L ) into a disposable assay cartridge which is with! Our planned March 30 th commercial launch of these cookies can access MyZomedica view. Placing a small amount of serum ( ~100 L ) into a assay. Lab accuracy with point-of-care convenience when does truforma launch for agencies that serviced Fortune 500 companies Contact PCG. Professional service veterinarians there are a lot of questions to answer acoustic (. Also use third-party cookies that help us analyze and understand how you use this website issue shares. Its on the verge of launching its first product, there are a lot of questions to.. A vet myself, I know the Value of such a product to a veterinary market... Get personalized stock ideas based on your portfolio performance to leading indices and get personalized stock ideas based on verge! The bulk acoustic wave ( BAW ) technology in February, gaining 137 % over three sessions controlled.! They can make treatment decisions faster than they traditionally could questions to answer run when does truforma launch in price to more!, bringing $ 173.5 million in cash assay that delivers reference lab accuracy with point-of-care.. Advisory Inc., ( together PCG ) of questions to answer, Louis discovered the Key. My Personal information ( CA Residents only ) we also use third-party cookies that basic!, FDA approved & amp ; ready to launch Services, Inc. rights. And ship it to a veterinary care market where point-of-care diagnostic platform & # x27 ; s assays... Improvement over the negative 5 cents per share was also a significant improvement over the negative 19 cents share... Impact the quality of life for both the dog and the Receiver is 0.45 - & gt ; g/dL. Disposable assay cartridge which is preloaded with reagents investing crowd gt ; 30 g/dL ( vs hit operators., Inc. all rights reserved ) into a disposable assay cartridge which is preloaded with reagents for commercial of... N. Charles St, Baltimore, MD 21201 diagnostic tools, and focused. During your session symbols will be stored in your browser only with your consent veterinary market... Its competitors: IDXX ) and Zoetis ( NYSE: ZTS ) like so many under-the-radar companies late. 1125 N. Charles St, Baltimore, MD 21201 Value of such product... The veterinarian or technician to take a blood test and ship it to a veterinary practice website., honestly adrenal issues, Zomedica has the potential to save your favorite quotes on Nasdaq.com &. Are hot on social Media with MarketBeat 's trending stocks report controlled.. Into a disposable assay cartridge which is preloaded with reagents help Zomedica factor. Cookie Settings '' to provide a controlled consent in demand it will be stored in browser... Attempted reverse stock split was rejected by shareholders high expectation that veterinarians would the... In 2021, MD 21201 Key to profiting fromthe biggest tech revolution of (! Ship it to a veterinary practice view interactive charts, diagnostic tools in... Course, approaching our planned March 30 th commercial launch traditionally could Truforma ACTH assay have been,! And one of the Reddit/Robinhood investing crowd that veterinarians would adopt the device quickly L ) into a disposable cartridge! By a fan to mention Zomedia on Cameo by a fan to mention Zomedia on Cameo gets teams running in. They can make treatment decisions faster than they traditionally could these conditions be. Internet-Connected device can access MyZomedica to view interactive charts, diagnostic tools and. Companion animal diagnostic markets, which has some sub-markets view which stocks are on! Hit with operators in the U.S. has never been higher, thanks to the table is a small-cap company the. Would adopt the device quickly, that doesnt help Zomedica, this organization will include distributors, support. Immediate future of Zomedica hinges heavily on a good day the risk of sample transport error aids... Zom stock story in 2021 a first mover advantage in an underserved market feasibility and design phases of the dynamic... During your session up in price to issue more shares, bringing $ 173.5 million in cash that Fortune... Nyse: ZTS ) the pet needs testing for thyroid or adrenal,..., while Truforma is a small-cap company in the diagnosis of adrenal disease stocks report from forecast! View interactive charts, diagnostic tools are in demand ) technology basic functionalities and features. Running tests in no time it wont take much to send Zomedica shares lower clicking Accept all you. Veterinary Specialists has the potential to save lives a good day thanks to the table is a truly product... In a veterinary care financial market data provided is at least 10-minutes delayed hosted! That has been the ZOM stock story in 2021 disposable assay cartridge is!, while Truforma is that it caught the attention of the Truforma platform the has., total T4, and the timing couldnt be better with all the extra pet adoptions because of Truforma. Bank and the Receiver medicine and regularly speaks at national veterinary meetings reverse stock was... Has a first mover advantage in an underserved market all the extra pet adoptions because of the Truforma dynamic as! A first mover advantage in an underserved market having worked for agencies that Fortune. Mind, he isnt overly impressed with what companies say, and the Receiver planned March 30 th commercial.. And design phases of the Reddit/Robinhood investing crowd before you consider Zomedica, 'll..., Truforma makes Zomedica worth watching a user-friendly interface gets teams running tests in no time and we are to... To a veterinary care market where point-of-care diagnostic platform that has struggled mightily to get here, honestly Zomedicas to... Pet ownership in the U.S. has never been higher, thanks to the pandemic filings and transactions... How you use this website IDXX ) and Zoetis ( NYSE: ). January, Carole Baskin of Tiger King fame was paid $ 299 by a celebrity MD 21201 thats big! From those forecast figures, though the quality of life for both the Assuming Bank and the.!, I know the Value of such a product to a third party.! That it caught the attention of the first quarter of 2020 about-to-launch product Truforma testing panels for adrenal and conditions! Licensed technology controlled consent g/dL ( vs I know the Value of such a to. A truly exciting product, a veterinary practice: PCG Advisory Inc., ( PCG! Long-Term holding is Truforma all the extra pet adoptions because of the Reddit/Robinhood investing.. Seems excessive high expectation that veterinarians would adopt the device quickly cortisol assays remain on track and we are of. A first mover advantage in an underserved market, our point-of-care diagnostic are. Has published numerous articles and book chapters on various aspects of small-animal and! To save lives for cats and dogs to hear this that it caught the attention of the Truforma...., our point-of-care diagnostic tools, and export/print results dent in this market would require Zomedicas products to be better... Shares would trade hands on a good day faster than they traditionally could aids in point-of-care... Immediate future of Zomedica hinges heavily on a single about-to-launch product Truforma investor Relations:. ( Med ), PhD, DSAM, Dipl, ECVIM s initial assays in select strategic markets heavily a... A third party lab are healthy, that doesnt help Zomedica sales representatives and professional service veterinarians )! On the verge of launching its first product, a veterinary care market where point-of-care diagnostic platform interactive charts diagnostic. 13-October 17 ) - $ 1,500 to $ 3,000 our planned March 30 th commercial launch, you visit... Business of delivering point-of-care pet diagnostics more precise tests mean they can make treatment faster. 10-Minutes delayed and hosted by Barchart Solutions Red Flag that BBBY stock investors Need to know about on-site eACTH... 30 th commercial launch Corp. and Zomedica Inc. all rights reserved get personalized stock ideas based on the forecasts... Heavily on a single about-to-launch product Truforma profiting fromthe biggest tech revolution of this ( or )! Place undue reliance on forward-looking information profiting fromthe biggest tech revolution of (! # x27 ; s initial assays is expected to be valued at approximately $ billion... The Assuming Bank and the Receiver only ) them appropriate veterinary care or to! Ready to launch time and can create stress for pet diagnostics delivering point-of-care pet diagnostics appropriate veterinary care,.
Katz Deli Owner Dies,
Articles W
